1,507
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Investigation of pharmacokinetics and immunogenicity of magnetosomes

ORCID Icon & ORCID Icon
Pages 69-83 | Received 15 Sep 2023, Accepted 22 Nov 2023, Published online: 12 Jan 2024

References

  • Nikalje AP. Nanotechnology and its applications in medicine. Med Chem. 2015;5(2):081–089. doi:10.4172/2161-0444.1000247].
  • Mabrouk M, Das DB, Salem ZA, et al. Nanomaterials for biomedical applications: production, characterisations, recent trends and difficulties. Molecules. 2021;26(4):1077. [PubMed: 33670668]. doi:10.3390/molecules26041077.
  • El-Zayat MM, Eraqi MM, Alrefai H, et al. The antimicrobial, antioxidant, and anticancer activity of greenly synthesized selenium and zinc composite nanoparticles using Ephedra aphylla extract. Biomolecules. 2021;11(3):470. [PubMed: 33809976]. doi:10.3390/biom11030470.
  • Magro M, Venerando A, Macone A, et al. Nanotechnology-based strategies to develop new anticancer therapies. Biomolecules. 2020;10(5):735. [PubMed: 32397196]. doi:10.3390/biom10050735.
  • Nikolova MP, Chavali MS. Metal oxide nanoparticles as biomedical materials. Biomimetics. 2020;5(2):27. [PubMed: 32521669]. doi:10.3390/biomimetics5020027.
  • Chenthamara D, Subramaniam S, Ramakrishnan SG, et al. Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res. 2019;23(1):20. [PubMed: 31832232]. doi:10.1186/s40824-019-0166-x.
  • Harish V, Tewari D, Gaur M, et al. Review on nanoparticles and nanostructured materials: bioimaging, biosensing, drug delivery, tissue engineering, antimicrobial, and agro-food applications. Nanomaterials (Basel). 2022;12(3):457. [PubMed: 35159802]. doi:10.3390/nano12030457.
  • Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124. [PubMed: 33277608]. doi:10.1038/s41573-020-0090-8.
  • Yao Y, Zang Y, Qu J, et al. The toxicity of metallic nanoparticles on liver: the subcellular damages, mechanisms, and outcomes. Int J Nanomedicine. 2019;14:8787–8804. [PubMed: 31806972]. doi:10.2147/IJN.S212907.
  • Amina SJ, Guo B. A review on the synthesis and functionalization of gold nanoparticles as a drug delivery vehicle. Int J Nanomed. 2020;15:9823–9857. [PubMed: 33324054]. doi:10.2147/IJN.S279094.
  • Tamargo J, Le Heuzey JY, Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015;71(5):549–567. [PubMed: 25870032]. doi:10.1007/s00228-015-1832-0.
  • Komeili A. Molecular mechanisms of compartmentalization and biomineralization in magnetotactic bacteria. FEMS Microbiol Rev. 2012;36(1):232–255. doi:10.1111/j.1574-6976.2011.00315.x.
  • Kianfar E. Magnetic nanoparticles in targeted drug delivery: a review. J Supercond Nov Magn. 2021;34(7):1709–1735. doi:10.1007/s10948-021-05932-9].
  • Kalubowilage M, Janik K, Bossmann SH. Magnetic nanomaterials for magnetically-aided drug delivery and hyperthermia. Appl Sci. 2019;9(14):2927. doi:10.3390/app9142927].
  • Materón EM, Miyazaki CM, Carr O, et al. Magnetic nanoparticles in biomedical applications: a review. Appl Surf Sci Adv. 2021;6:100163. doi:10.1016/j.apsadv.2021.100163].
  • Schüler D, Frankel RB. Bacterial magnetosomes: microbiology, biomineralization and biotechnological applications. Appl Microbiol Biotechnol. 1999;52(4):464–473. doi:10.1007/s002530051547.
  • Arakaki A, Nakazawa H, Nemoto M, et al. Formation of magnetite by bacteria and its application. J R Soc Interface. 2008;5(26):977–999. [PubMed: 18559314]. doi:10.1098/rsif.2008.0170.
  • Farjadian F, Moghoofei M, Mirkiani S, et al. Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: set the bugs to work? Biotechnol Adv. 2018;36(4):968–985. [PubMed: 29499341]. doi:10.1016/j.biotechadv.2018.02.016.
  • Sun J, Li Y, Liang XJ, et al. Bacterial magnetosome: a novel biogenetic magnetic targeted drug carrier with potential multifunctions. J Nanomater. 2011;2011(2011):469031–469043. [PubMed: 22448162]. doi:10.1155/2011/469031.
  • Raguraman V, Jayasri MA, Suthindhiran K. Magnetosome mediated oral insulin delivery and its possible use in diabetes management. J Mater Sci Mater Med. 2020;31(8):75. [PubMed: 32761252]. doi:10.1007/s10856-020-06417-2.
  • Revathy T, Jacob JJ, Jayasri MA, et al. Microbial biofilm prevention on wound dressing by nanobiocoating using magnetosomes-coupled lemon grass extract. IET Nanobiotechnol. 2017;11(6):738–745. doi:10.1049/iet-nbt.2016.0236].
  • Sannigrahi S, Kumar A, Mathiyarasu S, et al. Detection of Escherichia coli in food samples by magnetosome-based biosensor. Biotechnol Bioproc E. 2023;28(1):152–161. doi:10.1007/s12257-022-0235-1].
  • Raguraman V, Suthindhiran K. Comparative ecotoxicity assessment of magnetosomes and magnetite nanoparticles. Int J Environ Health Res. 2020a;30(1):13–25. [PubMed: 30714827]. doi:10.1080/09603123.2019.1570489.
  • Sannigrahi S, Suthindhiran K. Metal recovery from printed circuit boards by magnetotactic bacteria. Hydrometallurgy. 2019;187:113–124. doi:10.1016/j.hydromet.2019.05.007.
  • Raguraman V, Suthindhiran K. Comparative studies on functionalization of bacterial magnetic nanoparticles for drug delivery. J Clust Sci. 2020b;31(6):1275–1284. doi:10.1007/s10876-019-01737-y].
  • Karabasz A, Szczepanowicz K, Cierniak A, et al. In vivo studies on pharmacokinetics, toxicity and immunogenicity of polyelectrolyte nanocapsules functionalized with two different polymers: poly-L-glutamic acid or PEG. Int J Nanomed. 2019;14:9587–9602. [PubMed: 31824153]. doi:10.2147/IJN.S230865.
  • Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19:164–174. [PubMed: 24778671].
  • Sun JB, Tang T, Duan J, et al. Biocompatibility of bacterial magnetosomes: acute toxicity, immunotoxicity and cytotoxicity. Nanotoxicology. 2010;4(3):271–283. [PubMed: 20795909]. doi:10.3109/17435391003690531.
  • Jacob JJ, Suthindhiran K. Magnetotactic bacteria and magnetosomes - Scope and challenges. Mater Sci Eng C Mater Biol Appl. 2016;68:919–928. doi:10.1016/j.msec.2016.07.049.
  • Taher Z, Legge C, Winder N, et al. Magnetosomes and magnetosome mimics: preparation, cancer cell uptake and functionalization for future cancer therapies. Pharmaceutics. 2021;13(3):367. [PubMed: 33802121]. doi:10.3390/pharmaceutics13030367.
  • Khosroshahi ME, Asemani M. Synthesis, characterization and imaging of fluorescine isothiocyanate conjugated magnetite nanoparticles in MCF 7 breast cancer cell lines. Int J Nanomater Nanotechnol Nanomed. 2017;3:044–050. doi:10.17352/2455-3492.000020].
  • Mickoleit F, Jörke C, Geimer S, et al. Biocompatibility, uptake and subcellular localization of bacterial magnetosomes in mammalian cells. Nanoscale Adv. 2021;3(13):3799–3815. [PubMed: 34263139]. doi:10.1039/d0na01086c.
  • Wang P, Chen C, Chen C, et al. The interaction of bacterial magnetosomes and human liver cancer cells in vitro. J Magn Magn Mater. 2017;427:105–110. doi:10.1016/j.jmmm.2016.10.106].
  • Muthana M, Kennerley AJ, Hughes R, et al. Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nat Commun. 2015;6(1):8009. [PubMed: 26284300]. doi:10.1038/ncomms9009.
  • Salimi M, Sarkar S, Fathi S, et al. Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice. Int J Nanomed. 2018;13:1483–1493. [PubMed: 29559777]. doi:10.2147/IJN.S157293.
  • Wahajuddin, S.A. & Arora, S. (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.Int J Nanomedicine, 7, 3445–3471 [] [PubMed: 22848170]. doi:10.2147/IJN.S30320.
  • Poon W, Zhang YN, Ouyang B, et al. Elimination pathways of nanoparticles. ACS Nano. 2019;13(5):5785–5798. [PubMed: 30990673]. doi:10.1021/acsnano.9b01383.
  • Alphandéry E, Idbaih A, Adam C, et al. Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors. J Nanobiotechnol. 2019;17(1):126. doi:10.1186/s12951-019-0555-2.
  • Agashe HB, Dutta T, Garg M, et al. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. J Pharm Pharmacol. 2006;58(11):1491–1498. [PubMed: 17132212]. doi:10.1211/jpp.58.11.0010.
  • Andreev SM, Babakhin AA, Petrukhina AO, et al. Immunogenic and allergenic properties of fulleren conjugates with aminoacids and proteins. Dokl Biochem. 2000;370(1–6):4–7. [PubMed: 11977250].